BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29699925)

  • 1. Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.
    Szilágyi B; Skok Ž; Rácz A; Frlan R; Ferenczy GG; Ilaš J; Keserű GM
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1693-1698. PubMed ID: 29699925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Biochemical Evaluation of Lid-Open D-Amino Acid Oxidase Inhibitors.
    Szilágyi B; Hargitai C; Kelemen ÁA; Rácz A; Ferenczy GG; Volk B; Keserű GM
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30646619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.
    Szilágyi B; Kovács P; Ferenczy GG; Rácz A; Németh K; Visy J; Szabó P; Ilas J; Balogh GT; Monostory K; Vincze I; Tábi T; Szökő É; Keserű GM
    Bioorg Med Chem; 2018 May; 26(8):1579-1587. PubMed ID: 29472125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
    Hopkins SC; Heffernan ML; Saraswat LD; Bowen CA; Melnick L; Hardy LW; Orsini MA; Allen MS; Koch P; Spear KL; Foglesong RJ; Soukri M; Chytil M; Fang QK; Jones SW; Varney MA; Panatier A; Oliet SH; Pollegioni L; Piubelli L; Molla G; Nardini M; Large TH
    J Med Chem; 2013 May; 56(9):3710-24. PubMed ID: 23631755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Situ Click Chemistry for the Identification of a Potent D-Amino Acid Oxidase Inhibitor.
    Toguchi S; Hirose T; Yorita K; Fukui K; Sharpless KB; Ōmura S; Sunazuka T
    Chem Pharm Bull (Tokyo); 2016 Jul; 64(7):695-703. PubMed ID: 26686243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRAK-4 inhibitors. Part 1: a series of amides.
    Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast D-amino acid oxidase: structural basis of its catalytic properties.
    Pollegioni L; Diederichs K; Molla G; Umhau S; Welte W; Ghisla S; Pilone MS
    J Mol Biol; 2002 Nov; 324(3):535-46. PubMed ID: 12445787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.
    Duplantier AJ; Becker SL; Bohanon MJ; Borzilleri KA; Chrunyk BA; Downs JT; Hu LY; El-Kattan A; James LC; Liu S; Lu J; Maklad N; Mansour MN; Mente S; Piotrowski MA; Sakya SM; Sheehan S; Steyn SJ; Strick CA; Williams VA; Zhang L
    J Med Chem; 2009 Jun; 52(11):3576-85. PubMed ID: 19438227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations.
    Zhu K; Jiang C; Tao H; Liu J; Zhang H; Luo C
    Bioorg Med Chem Lett; 2018 May; 28(9):1476-1483. PubMed ID: 29628326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
    Szilágyi B; Ferenczy GG; Keserű GM
    Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of USP7 small-molecule allosteric inhibitors.
    Engström O; Belda O; Kullman-Magnusson M; Rapp M; Böhm K; Paul R; Henderson I; Derbyshire D; Karlström S; Parkes KEB; Zhao H
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127471. PubMed ID: 32781219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase.
    Raje M; Hin N; Duvall B; Ferraris DV; Berry JF; Thomas AG; Alt J; Rojas C; Slusher BS; Tsukamoto T
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3910-3. PubMed ID: 23683589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
    Torkar A; Lenarčič B; Lah T; Dive V; Devel L
    Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of small molecule sphingomyelin synthase inhibitors.
    Deng X; Lin F; Zhang Y; Li Y; Zhou L; Lou B; Li Y; Dong J; Ding T; Jiang X; Wang R; Ye D
    Eur J Med Chem; 2014 Feb; 73():1-7. PubMed ID: 24374347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques.
    Di Lello P; Pastor R; Murray JM; Blake RA; Cohen F; Crawford TD; Drobnick J; Drummond J; Kategaya L; Kleinheinz T; Maurer T; Rougé L; Zhao X; Wertz I; Ndubaku C; Tsui V
    J Med Chem; 2017 Dec; 60(24):10056-10070. PubMed ID: 29166018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.
    Hin N; Duvall B; Berry JF; Ferraris DV; Rais R; Alt J; Rojas C; Slusher BS; Tsukamoto T
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2088-91. PubMed ID: 26965861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of small molecules as potent glucosidase inhibitors.
    Hati S; Madurkar SM; Bathula C; Thulluri C; Agarwal R; Siddiqui FA; Dangi P; Adepally U; Singh A; Singh S; Sen S
    Eur J Med Chem; 2015 Jul; 100():188-96. PubMed ID: 26087029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New classes of potent heparanase inhibitors from ligand-based virtual screening.
    Pala D; Scalvini L; Elisi GM; Lodola A; Mor M; Spadoni G; Ferrara FF; Pavoni E; Roscilli G; Milazzo FM; Battistuzzi G; Rivara S; Giannini G
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1685-1696. PubMed ID: 32907434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of tautomeric and protomeric binding modes by free energy calculations. A case study for the structure based optimization of D-amino acid oxidase inhibitors.
    Orgován Z; Ferenczy GG; Steinbrecher T; Szilágyi B; Bajusz D; Keserű GM
    J Comput Aided Mol Des; 2018 Feb; 32(2):331-345. PubMed ID: 29335871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
    Lange JH; Venhorst J; van Dongen MJ; Frankena J; Bassissi F; de Bruin NM; den Besten C; de Beer SB; Oostenbrink C; Markova N; Kruse CG
    Eur J Med Chem; 2011 Oct; 46(10):4808-19. PubMed ID: 21880399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.